离子液体介导的乙体用于通过皮肤输送胰岛素
Fahmida Habib Nabila1, Rashedul Islam1, Islam Md Shimul2
1Department of Applied Chemistry, Graduate School of Engineering, Kyushu University, 744 Motooka, Nishi-ku, Fukuoka 819-0395, Japan. m-goto@mail.cstm.kyushu-u.ac.jp.
概括
使用1,2-二米里斯托尔-sn-glycero-3-phosphatidylcholine (DMPC) 离子液和乙醇的新型以索姆 (ET) 配方增强了通过皮肤递送胰岛素. 这些先进的ET显示出更好的稳定性,封装性和皮肤透性,以有效的药物输送.
科学领域:
- 制药科学 制药科学
- 药物输送系统 药物输送系统
- 纳米技术纳米技术
背景情况:
- 像胰岛素这样的高分子量药物通过皮肤传递面临着挑战.
- 传统的以体 (ET) 配方在稳定性和有效性方面存在局限性.
- 离子液体为新型药物输送系统提供了潜力.
研究的目的:
- 开发和评估用于增强通过皮肤输送胰岛素的新型以太体 (ET) 配方.
- 调查基于1,2-二米里斯托尔-sn-甘油-3-酸丁 (DMPC) 的离子液和乙醇度对ET特性的影响.
- 评估胰岛素装载ET的稳定性,封装效率和皮肤透性.
主要方法:
- 使用基于DMPC的离子液体和不同度的乙醇配制以体 (ETs).
- 在ET囊泡中封装胰岛素.
- 对ET囊泡大小,稳定性和药物封装效率的评估.
- 在体外评估ET配方胰岛素的皮肤透率.
主要成果:
- 与传统的DMPCET相比,胰岛素载入的ET囊泡显示出长期稳定性.
- 新型ET配方表现出明显更高的胰岛素封装效率.
- 在开发的ET时,观察到胰岛素的皮肤透能力增加.
- 乙醇度被优化以改善配方特性.
结论:
- 基于DMPC的离子液体乙体为通过皮肤输送胰岛素提供了一个有前途的平台.
- 这些新的ET配方克服了传统系统的局限性,提高了稳定性和药物透性.
- 这些发现支持这种方法在非侵入性胰岛素治疗中的潜力.
相关概念视频
Insulin Formulations: Types and Delivery
193
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
193
Insulin: Biosynthesis, Chemistry, and Preparation
375
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
375


